跳至主要内容
临床试验/CTRI/2019/05/018990
CTRI/2019/05/018990已完成4 期

A comparative study of the safety, efficacy, quality of life outcome and pharmacoeconomics of levetiracetam with controlled-release carbamazepine in patients of new onset focal seizures

Institutional sponsored0 个研究点目标入组 74 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • The study will include all the newly diagnosed consenting adult patients of focal seizures without any other co-morbidities

排除标准

  • Patients not willing to give written informed consent.
  • Pregnant females.
  • Patients already on treatment with study drugs.
  • Patients of seizures others than focal seizures.
  • Patients of head trauma within past one month.
  • Patients with known contraindication or refractoriness to study drugs.

研究者

发起方
Institutional sponsored

相似试验